| Serial Number | 97753516 |
| Word Mark | QINECSA SOLUTIONS |
| Filing Date | Friday, January 13, 2023 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Thursday, October 31, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 12, 2024 |
| Goods and Services | Educational services, namely, classes, seminars and training in the fields of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; conducting seminars and workshops in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; publication of books; publication of electronic books and journals on-line; providing on-line non-downloadable electronic publications, namely, books, magazines, journals, texts and documents in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid |
| Goods and Services | Downloadable computer software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, enabling follow-up questions and answers regarding said reactions and events and producing reports regarding such reactions and events; downloadable computer programs for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; downloadable computer software applications for capturing information concerning reactions and events resulting from the use of medication and pharmaceuticals, for enabling follow-up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; Downloadable computer software and downloadable computer software applications for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs |
| Goods and Services | Outsourcing services, namely, arranging of service contracts and procurement of goods or services for others; business consultancy; business consulting, business assistance, and business management in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; database management in the field of drug and pharmaceutical safety testing, pharmacovigilance clinical trials, and capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting; information, advisory and consultancy services relating to all the aforesaid |
| Goods and Services | Consultancy services in the field of regulatory compliance and regulatory compliance auditing in the pharmaceutical field |
| NOT AVAILABLE | "SOLUTIONS" |
| Goods and Services | Software as a service (SAAS) services featuring software for capturing information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, for enabling follow up questions and answers regarding said reactions and events and for producing reports regarding such reactions and events; providing temporary use of on-line non-downloadable software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals, as well as enabling follow-up questions and answers regarding said quality, reactions and events and enables the production of reports regarding said reactions and events; maintenance of computer software which enables the capture of information concerning reactions and events resulting from the use of medication and/or pharmaceuticals and enables follow-up questions and answers regarding said reactions and events; Scientific and technological services, namely, scientific research and design in the fields of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; providing medical research information; medical research and product development; design and development of computer software; pharmacovigilance services for others, namely, scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Medical and scientific research, namely, conducting clinical trials; Medical and scientific research, namely, conducting clinical trials for pharmaceutical and biotechnology products; providing medical and scientific research information in the field of drug and pharmaceutical safety testing, pharmacovigilance, clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance; inspection of medicines; drug safety, namely, product quality testing and evaluation; Pharmaceutical drug development services; testing of medicines and vaccines; inspection of medicines and vaccines; information technology consulting services relating to installation, maintenance and repair of computer software for the pharmaceutical, biotechnology and healthcare industries; providing scientific information about the results of clinical trials; consultancy services in the fields of drug and pharmaceutical safety testing, medical and scientific research for clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance and pharmacovigilance, namely scientific research and analysis pertaining to adverse events and product quality complaints regarding pharmaceutical products, assessment of risks presented by certain pharmaceutical products or combinations thereof, and product safety testing and consultation related thereto in the field of pharmaceuticals; Software as a service (SaaS) featuring software for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; Providing on-line non-downloadable software using artificial intelligence for use in data processing in drug and pharmaceutical safety testing, pharmacovigilance, namely, monitoring the effects of medical drugs, data processing in clinical trials, capturing, managing, processing and evaluating drug safety data, and related quality assurance, auditing and regulatory compliance and reporting for drugs; information, advisory and consultancy services relating to all the aforesaid |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 3, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 3, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 3, 2023 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 10, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 10, 2024 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Qinecsa Solutions, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Princeton, NJ 08540 |
| Party Name | Qinecsa Solutions, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Princeton, NJ 08540 |
| Event Date | Event Description |
| Tuesday, January 17, 2023 | NEW APPLICATION ENTERED |
| Friday, February 3, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 11, 2023 | ASSIGNED TO EXAMINER |
| Thursday, October 12, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, October 12, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, October 12, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 10, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 10, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 10, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, January 11, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Thursday, January 11, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 11, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, January 11, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, January 16, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, January 19, 2024 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Thursday, February 1, 2024 | ELECTRONIC RECORD REVIEW COMPLETE |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 7, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, October 31, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, October 31, 2024 | SOU EXTENSION 1 GRANTED |
| Thursday, October 31, 2024 | SOU EXTENSION 1 FILED |
| Thursday, October 31, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |